Association of KCNJ11 rs5219 gene polymorphism with type 2 diabetes mellitus in a population of Syria: a case-control study
- PMID: 31195986
- PMCID: PMC6567472
- DOI: 10.1186/s12881-019-0846-3
Association of KCNJ11 rs5219 gene polymorphism with type 2 diabetes mellitus in a population of Syria: a case-control study
Abstract
Background: Type 2 diabetes mellitus is believed to be a polygenic disorder that develops as a result of a complex interaction between multiple genes and environmental factors. KCNJ11 gene encodes a Kir6.2 protein which forms the inner section of the potassium channels in pancreatic beta cells. Several studies found that KCNJ11 polymorphism increases T2DM risk. Our study aimed to investigate the association between rs5219 polymorphism of the KCNJ11 gene and T2DM in Syrian patients.
Methods: This case-control study involved 75 T2DM patients and 63 healthy controls. The KCNJ11 rs5219 polymorphism was genotyped by Restriction Fragment Length Polymorphism (RFLP).
Results: The frequency of the risk allele K was similar between the two groups (38.7% vs. 38.1%, P = 0.132). The frequency of the KK genotype was higher among the patients' group (16% vs. 4.8%), and the frequency of the EK genotype was higher among the control group (45.3% vs. 66.6%); however, the differences were statistically insignificant. The KK genotype was significantly associated with T2DM in the recessive model with an OR of 3.81 (95% CI 1.024-14.17, P = 0.035).
Conclusions: This study showed that rs5219 polymorphism of the KCNJ11 gene is an important risk factor for type 2 diabetes mellitus in a sample of the Syrian population.
Keywords: Beta cells; KCNJ11; Polymorphism; Potassium channels; RFLP; Syria; Type 2 diabetes; rs5219.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Potassium inwardly-rectifying channel subfamily J member 11 (KCNJ11) gene polymorphism in Egyptian type 2 diabetic patients: a single-center study.Mol Biol Rep. 2024 Nov 7;51(1):1129. doi: 10.1007/s11033-024-10035-4. Mol Biol Rep. 2024. PMID: 39508922
-
Association of Kir6.2 gene rs5219 variation with type 2 diabetes: A meta-analysis of 21,464 individuals.Prim Care Diabetes. 2018 Aug;12(4):345-353. doi: 10.1016/j.pcd.2018.03.004. Epub 2018 Apr 22. Prim Care Diabetes. 2018. PMID: 29685723 Review.
-
Genetic polymorphisms in KCNJ11 (E23K, rs5219) and SDF-1β (G801A, rs1801157) genes are associated with the risk of type 2 diabetes mellitus.Br J Biomed Sci. 2018 Jul;75(3):139-144. doi: 10.1080/09674845.2018.1473939. Epub 2018 Jun 12. Br J Biomed Sci. 2018. PMID: 29893194
-
Polymorphism E23K (rs5219) in the KCNJ11 gene in Euro-Brazilian subjects with type 1 and 2 diabetes.Genet Mol Res. 2017 Apr 5;16(2). doi: 10.4238/gmr16029543. Genet Mol Res. 2017. PMID: 28387875
-
ATP-dependent potassium channels and type 2 diabetes mellitus.Clin Biochem. 2015 May;48(7-8):476-82. doi: 10.1016/j.clinbiochem.2014.12.026. Epub 2015 Jan 10. Clin Biochem. 2015. PMID: 25583094 Review.
Cited by
-
Potassium inwardly-rectifying channel subfamily J member 11 (KCNJ11) gene polymorphism in Egyptian type 2 diabetic patients: a single-center study.Mol Biol Rep. 2024 Nov 7;51(1):1129. doi: 10.1007/s11033-024-10035-4. Mol Biol Rep. 2024. PMID: 39508922
-
Identifying the association between single nucleotide polymorphisms in KCNQ1, ARAP1, and KCNJ11 and type 2 diabetes mellitus in a Chinese population.Int J Med Sci. 2020 Aug 29;17(15):2379-2386. doi: 10.7150/ijms.48072. eCollection 2020. Int J Med Sci. 2020. PMID: 32922204 Free PMC article.
-
Association of KCNJ11 E23K/rs5219 Gene Polymorphism with Type 2 Diabetes and Diabetes-Related Cardiovascular Disease.Diabetes Metab Syndr Obes. 2025 Feb 27;18:653-661. doi: 10.2147/DMSO.S506639. eCollection 2025. Diabetes Metab Syndr Obes. 2025. PMID: 40034481 Free PMC article.
-
Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population.Hum Genomics. 2022 Apr 2;16(1):11. doi: 10.1186/s40246-022-00383-2. Hum Genomics. 2022. PMID: 35366956 Free PMC article. Review.
-
Pharmacogenomics of sulfonylureas in type 2 diabetes mellitus; a systematic review.J Diabetes Metab Disord. 2021 Dec 1;21(1):863-879. doi: 10.1007/s40200-021-00908-x. eCollection 2022 Jun. J Diabetes Metab Disord. 2021. PMID: 35673432 Free PMC article. Review.
References
-
- National Diabetes Statistics Report, 2017 Estimates of Diabetes and Its Burden in the United States2017. https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-stat.... Accessed Feb 2018.
-
- World Health Organization – Diabetes country profiles, Syrian Arab Republic, 2016. https://www.who.int/diabetes/country-profiles/syr_en.pdf?ua=1.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials